年轻供卵受者的围产结局
该回顾性队列研究基于美国国家辅助生殖技术监测系统2010至2015年数据,纳入年龄小于35岁的女性新鲜和冻融辅助生殖周期,比较供卵与自体卵母细胞的围产结局。在71720例单胎妊娠中,供卵者早产和低出生体重的调整风险比分别为1.39和1.34;当无胚胎冷冻保存时,供卵与死产风险升高相关(aRR 3.73),而至少一个胚胎冷冻保存时未见关联。
要点
- 小于35岁女性新鲜周期中,供卵单胎早产风险高于自体卵(15.6% vs 11.0%,aRR 1.39)。
- 供卵单胎低出生体重风险亦升高(11.8% vs 8.8%,aRR 1.34)。
- 无胚胎冷冻保存时,供卵与死产风险升高相关(aRR 3.73);有胚胎冷冻时未见关联。
核心结论
- 在小于35岁女性新鲜辅助生殖周期中,供卵与早产、低出生体重及无胚胎冷冻保存时的死产风险升高相关,相较于自体卵母细胞。
研究设计与样本
- 回顾性队列研究,使用美国疾病控制与预防中心国家辅助生殖技术监测系统2010至2015年数据,纳入小于35岁女性新鲜和冻融的自体或供卵周期,排除冻卵、捐赠胚胎或代孕周期。
主要发现
- 在71720例单胎妊娠中,供卵单胎早产率15.6% vs 自体卵11.0%(aRR 1.39,95%CI 1.20-1.61),低出生体重率11.8% vs 8.8%(aRR 1.34,95%CI 1.16-1.55)。
- 无胚胎冷冻保存时,供卵与自体卵相比死产风险升高(2.1% vs 0.6%,aRR 3.73,95%CI 1.96-7.11)。
- 至少一个胚胎冷冻保存时,供卵与死产无显著关联(0.54% vs 0.56%,aRR 1.15,95%CI 0.59-2.25)。
局限性
- 数据来自国家监测系统,受各提供者和诊所录入数据准确性的限制。
- 使用供卵与自体卵的女性之间可能存在未测量的差异,可能导致所报告的关联。
- 鉴于样本量大,统计学显著的发现可能不反映临床上重要的差异。
- 原文结论提出需进一步研究供卵受者妊娠潜在风险增加的病理生理机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is the use of donor oocytes in women <35 years of age associated with an increased risk of adverse perinatal outcomes compared to use of autologous oocytes? SUMMARY ANSWER: Among fresh assisted reproductive technology (ART) cycles performed in women under age 35, donor oocyte use is associated with a higher risk of preterm birth, low birth weight and stillbirth (when zero embryos were cryopreserved) as compared to autologous oocytes. WHAT IS KNOWN ALREADY: Previous studies demonstrated elevated risk of poor perinatal outcomes with donor versus autologous oocytes during ART, primarily among older women. STUDY DESIGN, SIZE, DURATION: Retrospective cohort study using data reported to Centers for Disease Control and Prevention's National ART Surveillance System (NASS) during the period from 2010 to 2015 in order to best reflect advances in clinical practice. Approximately 98% of all US ART cycles are reported to NASS, and discrepancy rates were <6% for all fields evaluated in 2015. PARTICIPANTS/MATERIALS, SETTING, METHODS: We included all non-banking fresh and frozen ART cycles performed between 2010 and 2015 in women under age 35 using autologous or donor eggs. Cycles using cryopreserved eggs, donated embryos or a gestational carrier were excluded. Among fresh embryo transfer cycles, we calculated predicted marginal proportions to estimate the unadjusted and adjusted risk ratios (aRRs) and 95% confidence intervals (CIs) for the association between donor versus autologous oocyte use and stillbirth, spontaneous abortion, preterm delivery and low birth weight among singleton pregnancies or births. Stillbirth models were stratified by number of embryos cryopreserved. All models were adjusted for patient and treatment characteristics. MAIN RESULTS AND THE ROLE OF CHANCE: Among the 71 720 singleton pregnancies occurring during 2010-2015, singletons resulting from donor oocytes were more likely to be preterm (15.6% versus 11.0%; aRRs 1.39: CI 1.20-1.61) and have low birth weight (11.8% versus 8.8%; aRRs 1.34; CI 1.16-1.55) than those resulting from autologous oocytes. With zero embryos cryopreserved, donor versus autologous oocyte use was associated with increased risk for stillbirth (2.1% versus 0.6%; aRRs 3.73; CI 1.96-7.11); no association with stillbirth was found when ≥1 embryo was cryopreserved (0.54% versus 0.56%; aRR 1.15; CI 0.59-2.25). LIMITATIONS, REASONS FOR CAUTION: The data come from a national surveillance system and is thus limited by the accuracy of the data entered by individual providers and clinics. There may be unmeasured differences between women using donor eggs versus their own eggs that could be contributing to the reported associations. Given the large sample size, statistically significant findings may not reflect clinically important variations. WIDER IMPLICATIONS OF THE FINDINGS: Risks of preterm birth, low birth weight and stillbirth among singleton pregnancies using donor oocytes were increased compared to those using autologous oocytes. Further study regarding the pathophysiology of the potentially increased risks among donor oocyte recipient pregnancy is warranted. STUDY FUNDING/COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: N/A.
引用
- Schwartz KM, Boulet SL, Kawwass JF, et al. Perinatal outcomes among young donor oocyte recipients. Hum Reprod. 2019. PMID: 31750511. doi:10.1093/humrep/dez213
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。